GLP-1 Against Brain Protein Aggregation: Targeting Amyloid, Tau, and Alpha-Synuclein
Review of GLP-1 effects on amyloid-beta, tau, and alpha-synuclein covers how GLP-1 drugs may protect against the three major neurodegenerative protein aggregates.
Quick Facts
What This Study Found
Review of GLP-1 effects on amyloid-beta, tau, and alpha-synuclein covers how GLP-1 drugs may protect against the three major neurodegenerative protein aggregates.
Key Numbers
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Review of GLP-1 effects on amyloid-beta, tau, and alpha-synuclein covers how GLP-1 drugs may protect
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Role of Glucagon-Like Peptide-1 on Amyloid, Tau, and α-Synuclein: Target Engagement and Rationale for the Development in Neurodegenerative Disorders.
- Published In:
- Neuroscience and biobehavioral reviews, 173, 106159 (2025)
- Authors:
- Au, Hezekiah C T(5), Lam, Pak Ho(2), Lim, Poh Khuen, McIntyre, Roger S
- Database ID:
- RPEP-10012
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Review of GLP-1 effects on amyloid-beta, tau, and alpha-synuclein covers how GLP-1 drugs may protect against the three major neurodegenerative protein aggregates.
How reliable?
Consult publication.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10012APA
Au, Hezekiah C T; Lam, Pak Ho; Lim, Poh Khuen; McIntyre, Roger S. (2025). Role of Glucagon-Like Peptide-1 on Amyloid, Tau, and α-Synuclein: Target Engagement and Rationale for the Development in Neurodegenerative Disorders.. Neuroscience and biobehavioral reviews, 173, 106159. https://doi.org/10.1016/j.neubiorev.2025.106159
MLA
Au, Hezekiah C T, et al. "Role of Glucagon-Like Peptide-1 on Amyloid, Tau, and α-Synuclein: Target Engagement and Rationale for the Development in Neurodegenerative Disorders.." Neuroscience and biobehavioral reviews, 2025. https://doi.org/10.1016/j.neubiorev.2025.106159
RethinkPeptides
RethinkPeptides Research Database. "Role of Glucagon-Like Peptide-1 on Amyloid, Tau, and α-Synuc..." RPEP-10012. Retrieved from https://rethinkpeptides.com/research/au-2025-role-of-glucagonlike-peptide1
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.